Most Popular

FBR Capital Remains Positive on FireEye Inc (FEYE) Following Analyst Day

FBR Capital analyst Daniel Ives weighed in today with a few insights on FireEye Inc (NASDAQ:FEYE) after attending the company’s Analyst Day yesterday, where market opportunities, …

Yelp Inc (YELP) Versus Google Inc (GOOGL) Plus Review Growth: Piper Jaffray

Gene Munster, managing director and senior research analyst at Piper Jaffray, weighed in today with a research report on Yelp Inc (NYSE:YELP) and Google Inc (NASDAQ:GOOGL). The analyst measured …

Roth Capital Shines Light on Synta Pharmaceuticals Corp. (SNTA) GANNET53 Program

Roth Capital’s healthcare analyst Joseph Pantginis weighed in with a few insights on Synta Pharmaceuticals Corp. (NASDAQ:SNTA), after the company announced the enrollment of the …

Walt Disney Co (DIS) Struggles Above $110

“I cant believe it, but I have to and I must.” The quoted words are truth spoken as it pertains to the stock …

Cowen Reiterates Outperform on Synta Pharmaceuticals Corp. Following Ganetespib Program Updates

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has been reiterated as a Buy at Cowen by research analyst Boris Peaker.

Now The ‘Dollar’ Becomes The Enemy; A Cycle Indication?

By Jeffrey P. Snider  If there is some small gain to be had from current economic circumstances, it might be a lesson in …

Juno Therapeutics Inc (JUNO)’s Multiple Sources of Technology May Prove To Be A Competitive Advantage Over Time: J.P. Morgan

Juno Therapeutics Inc (NASDAQ:JUNO) shares have taken off, adding 13.72% to trade at $60.

Takeways from ASCO 2015: Innate Pharma SA, Oncothyreon Inc (USA), and Affimed NV

By Zack Fink and Jake King Innate Pharma SA (EPA:IPH) presented data from the phase I dose-escalation study of lirilumab in patients with hematologic …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts